Cargando…
Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review
Autores principales: | Chan, Kathryn, Sharif, Sameer, Rochwerg, Bram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780596/ https://www.ncbi.nlm.nih.gov/pubmed/33534117 http://dx.doi.org/10.1007/s43678-020-00033-3 |
Ejemplares similares
-
CJEM journal club: corticosteroids use for critically ill COVID-19 patients
por: Li, Siying S., et al.
Publicado: (2021) -
Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial
por: Durr, Kevin M., et al.
Publicado: (2022) -
Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
por: Kareemi, Hashim, et al.
Publicado: (2021) -
Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial
por: Durr, Kevin M., et al.
Publicado: (2022) -
Does ketamine provide a shorter time to sedation when compared to haloperidol and midazolam in the agitated ED patient?
por: Kent, Jessica, et al.
Publicado: (2021)